NUWELLIS, INC. Research and Development Expense
NUWELLIS, INC. (NUWE) reported Research and Development Expense of $942.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-08-13
- NUWELLIS, INC. research and development expense for the quarter ending 2026-06-30 was $942.00K, a 39.56% increase year-over-year.
- NUWELLIS, INC. research and development expense for the quarter ending 2026-03-31 was $1.73M, a 214.18% increase year-over-year.
- NUWELLIS, INC. research and development expense for the quarter ending 2025-12-31 was $884.00K, a 6.38% increase year-over-year.
- NUWELLIS, INC. research and development expense for the quarter ending 2025-09-30 was $603.00K, a 24.07% increase year-over-year.
- NUWELLIS, INC. research and development expense for fiscal 2025 was $2.71M, a 15.49% decline from fiscal 2024.
- NUWELLIS, INC. research and development expense for fiscal 2024 was $3.21M, a 40.82% decline from fiscal 2023.
- NUWELLIS, INC. research and development expense for fiscal 2023 was $5.42M, a 24.87% increase from fiscal 2022.
- NUWELLIS, INC. research and development expense for fiscal 2022 was $4.34M, a 12.78% decline from fiscal 2021.
| Period end | Research and Development Expense 3 month | Research and Development Expense 6 month | Research and Development Expense 9 month | Research and Development Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $942.00K 10-Q · filed 2026-08-13 | $2.67M 10-Q · filed 2026-08-13 | $3.55M derived: sum of 3 quarters · filed 2026-08-13 | $4.16M derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | $1.73M 10-Q · filed 2026-05-15 | $2.61M derived: sum of 2 quarters · filed 2026-05-15 | $3.21M derived: sum of 3 quarters · filed 2026-05-15 | $3.89M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | $884.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-11 | $1.49M derived: sum of 2 quarters · filed 2026-03-11 | $2.16M derived: sum of 3 quarters · filed 2026-08-13 | $2.71M 10-K · filed 2026-03-11 |
| 2025-09-30 | $603.00K 10-Q · filed 2025-11-12 | $1.28M derived: sum of 2 quarters · filed 2026-08-13 | $1.83M 10-Q · filed 2025-11-12 | $2.66M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | $675.00K 10-Q · filed 2026-08-13 | $1.23M 10-Q · filed 2026-08-13 | $2.06M derived: sum of 3 quarters · filed 2026-08-13 | $2.54M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | $550.00K 10-Q · filed 2026-05-15 | $1.38M derived: sum of 2 quarters · filed 2026-05-15 | $1.87M derived: sum of 3 quarters · filed 2026-05-15 | $2.42M derived: sum of 4 quarters · filed 2026-05-15 |
| 2024-12-31 | $831.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-11 | $1.32M derived: sum of 2 quarters · filed 2026-03-11 | $1.88M derived: sum of 3 quarters · filed 2026-03-11 | $3.21M 10-K · filed 2026-03-11 |
| 2024-09-30 | $486.00K 10-Q · filed 2025-11-12 | $1.04M derived: sum of 2 quarters · filed 2025-11-12 | $2.38M 10-Q · filed 2025-11-12 | $3.75M derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | $558.00K 10-Q · filed 2025-08-14 | $1.89M 10-Q · filed 2025-08-14 | $3.26M derived: sum of 3 quarters · filed 2025-08-14 | $4.38M derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | $1.33M 10-Q · filed 2025-05-13 | $2.71M derived: sum of 2 quarters · filed 2025-05-13 | $3.82M derived: sum of 3 quarters · filed 2025-05-13 | $5.33M derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | $1.37M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11 | $2.49M derived: sum of 2 quarters · filed 2025-03-11 | $3.99M derived: sum of 3 quarters · filed 2025-03-11 | $5.42M 10-K · filed 2025-03-11 |
| 2023-09-30 | $1.12M 10-Q · filed 2024-11-12 | $2.62M derived: sum of 2 quarters · filed 2024-11-12 | $4.05M 10-Q · filed 2024-11-12 | $5.25M derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | $1.50M 10-Q · filed 2024-08-13 | $2.93M 10-Q · filed 2024-08-13 | $4.13M derived: sum of 3 quarters · filed 2024-08-13 | $5.06M derived: sum of 4 quarters · filed 2024-08-13 |
| 2023-03-31 | $1.43M 10-Q · filed 2024-05-08 | $2.63M derived: sum of 2 quarters · filed 2024-05-08 | $3.56M derived: sum of 3 quarters · filed 2024-05-08 | $4.66M derived: sum of 4 quarters · filed 2024-05-08 |
| 2022-12-31 | $1.20M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-11 | $2.13M derived: sum of 2 quarters · filed 2024-03-11 | $3.24M derived: sum of 3 quarters · filed 2024-03-11 | $4.34M 10-K · filed 2024-03-11 |
| 2022-09-30 | $928.00K 10-Q · filed 2023-11-07 | $2.04M derived: sum of 2 quarters · filed 2023-11-07 | $3.14M 10-Q · filed 2023-11-07 | $4.27M derived: sum of 4 quarters · filed 2023-11-07 |
| 2022-06-30 | $1.11M 10-Q · filed 2023-08-08 | $2.21M 10-Q · filed 2023-08-08 | $3.34M derived: sum of 3 quarters · filed 2023-08-08 | $5.07M derived: sum of 4 quarters · filed 2023-08-08 |
| 2022-03-31 | $1.11M 10-Q · filed 2023-05-09 | $2.24M derived: sum of 2 quarters · filed 2023-05-09 | $3.96M derived: sum of 3 quarters · filed 2023-05-09 | $5.14M derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | $1.13M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-03 | $2.86M derived: sum of 2 quarters · filed 2023-03-03 | $4.03M derived: sum of 3 quarters · filed 2023-03-03 | $4.98M 10-K · filed 2023-03-03 |
| 2021-09-30 | $1.73M 10-Q · filed 2022-11-08 | $2.90M derived: sum of 2 quarters · filed 2022-11-08 | $3.85M 10-Q · filed 2022-11-08 | $4.89M derived: sum of 4 quarters · filed 2022-11-08 |
| 2021-06-30 | $1.17M 10-Q · filed 2022-08-11 | $2.12M 10-Q · filed 2022-08-11 | $3.17M derived: sum of 3 quarters · filed 2022-08-11 | $4.04M derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | $947.00K 10-Q · filed 2022-05-12 | $2.00M derived: sum of 2 quarters · filed 2022-05-12 | $2.87M derived: sum of 3 quarters · filed 2022-05-12 | $3.75M derived: sum of 4 quarters · filed 2022-05-12 |
| 2020-12-31 | $1.05M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-03 | $1.92M derived: sum of 2 quarters · filed 2022-03-03 | $2.80M derived: sum of 3 quarters · filed 2022-03-03 | $3.67M 10-K · filed 2022-03-03 |
| 2020-09-30 | $871.00K 10-Q · filed 2021-11-10 | $1.76M derived: sum of 2 quarters · filed 2021-11-10 | $2.62M 10-Q · filed 2021-11-10 | $3.57M derived: sum of 4 quarters · filed 2021-11-10 |
| 2020-06-30 | $885.00K 10-Q · filed 2021-08-12 | $1.75M 10-Q · filed 2021-08-12 | $2.70M derived: sum of 3 quarters · filed 2021-08-12 | $3.81M derived: sum of 4 quarters · filed 2021-08-12 |
| 2020-03-31 | $864.00K 10-Q · filed 2021-05-13 | $1.82M derived: sum of 2 quarters · filed 2021-05-13 | $2.93M derived: sum of 3 quarters · filed 2021-05-13 | $4.23M derived: sum of 4 quarters · filed 2021-05-13 |
| 2019-12-31 | $953.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | $2.06M derived: sum of 2 quarters · filed 2021-03-25 | $3.36M derived: sum of 3 quarters · filed 2021-03-25 | $4.67M 10-K · filed 2021-03-25 |
| 2019-09-30 | $1.11M 10-Q · filed 2020-11-12 | $2.41M derived: sum of 2 quarters · filed 2020-11-12 | $3.72M 10-Q · filed 2020-11-12 | $4.67M derived: sum of 4 quarters · filed 2020-11-12 |
| 2019-06-30 | $1.30M 10-Q · filed 2020-08-05 | $2.61M 10-Q · filed 2020-08-05 | $3.55M derived: sum of 3 quarters · filed 2020-08-05 | $4.54M derived: sum of 4 quarters · filed 2020-08-05 |
| 2019-03-31 | $1.31M 10-Q · filed 2020-05-14 | $2.26M derived: sum of 2 quarters · filed 2020-05-14 | $3.24M derived: sum of 3 quarters · filed 2020-05-14 | $3.88M derived: sum of 4 quarters · filed 2020-05-14 |
| 2018-12-31 | $946.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-05 | $1.93M derived: sum of 2 quarters · filed 2020-03-05 | $2.57M derived: sum of 3 quarters · filed 2020-03-05 | $3.05M 10-K · filed 2020-03-05 |
| 2018-09-30 | $985.00K 10-Q · filed 2019-11-08 | $1.63M derived: sum of 2 quarters · filed 2019-11-08 | $2.11M 10-Q · filed 2019-11-08 | $2.59M derived: sum of 4 quarters · filed 2019-11-08 |
| 2018-06-30 | $643.00K 10-Q · filed 2019-08-08 | $1.12M 10-Q · filed 2019-08-08 | $1.60M derived: sum of 3 quarters · filed 2019-08-08 | $1.97M derived: sum of 4 quarters · filed 2019-08-08 |
| 2018-03-31 | $479.00K 10-Q · filed 2019-05-09 | $958.00K derived: sum of 2 quarters · filed 2019-05-09 | $1.32M derived: sum of 3 quarters · filed 2019-05-09 | $1.65M derived: sum of 4 quarters · filed 2019-05-09 |
| 2017-12-31 | $479.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-21 | $846.00K derived: sum of 2 quarters · filed 2019-02-21 | $1.17M derived: sum of 3 quarters · filed 2019-02-21 | $1.48M 10-K · filed 2019-02-21 |
| 2017-09-30 | $367.00K 10-Q · filed 2018-11-07 | $694.00K derived: sum of 2 quarters · filed 2018-11-07 | $1.00M 10-Q · filed 2018-11-07 | $1.60M derived: sum of 4 quarters · filed 2018-11-07 |
| 2017-06-30 | $327.00K 10-Q · filed 2018-08-09 | $635.00K 10-Q · filed 2018-08-09 | $1.23M derived: sum of 3 quarters · filed 2018-08-09 | $2.97M derived: sum of 4 quarters · filed 2018-08-09 |
| 2017-03-31 | $308.00K 10-Q · filed 2018-05-10 | $906.00K derived: sum of 2 quarters · filed 2018-05-10 | $2.64M derived: sum of 3 quarters · filed 2018-05-10 | $5.21M derived: sum of 4 quarters · filed 2018-05-10 |
| 2016-12-31 | $598.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-22 | $2.33M derived: sum of 2 quarters · filed 2018-03-22 | $4.90M derived: sum of 3 quarters · filed 2018-03-22 | $8.11M 10-K · filed 2018-03-22 |
| 2016-09-30 | $1.74M 10-Q · filed 2017-11-02 | $4.30M derived: sum of 2 quarters · filed 2017-11-02 | $7.51M 10-Q · filed 2017-11-02 | $11.78M derived: sum of 4 quarters · filed 2017-11-02 |
| 2016-06-30 | $2.57M 10-Q · filed 2017-08-10 | $5.78M 10-Q · filed 2017-08-10 | $10.04M derived: sum of 3 quarters · filed 2017-08-10 | $14.59M derived: sum of 4 quarters · filed 2017-08-10 |
| 2016-03-31 | $3.21M 10-Q · filed 2017-05-12 | $7.47M derived: sum of 2 quarters · filed 2017-05-12 | $12.02M derived: sum of 3 quarters · filed 2017-05-12 | $16.01M derived: sum of 4 quarters · filed 2017-05-12 |
| 2015-12-31 | $4.27M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-08 | $8.82M derived: sum of 2 quarters · filed 2017-03-08 | $12.81M derived: sum of 3 quarters · filed 2017-03-08 | $17.67M 10-K · filed 2017-03-08 |
| 2015-09-30 | $4.55M 10-Q · filed 2016-11-14 | $8.54M derived: sum of 2 quarters · filed 2016-11-14 | $13.40M 10-Q · filed 2016-11-14 | $17.99M derived: sum of 4 quarters · filed 2016-11-14 |
| 2015-06-30 | $3.99M 10-Q · filed 2016-08-11 | $8.86M 10-Q · filed 2016-08-11 | $13.45M derived: sum of 3 quarters · filed 2016-08-11 | $17.25M derived: sum of 4 quarters · filed 2016-08-11 |
| 2015-03-31 | $4.87M 10-Q · filed 2016-05-05 | $9.46M derived: sum of 2 quarters · filed 2016-05-05 | $13.26M derived: sum of 3 quarters · filed 2016-05-05 | $17.68M derived: sum of 4 quarters · filed 2016-05-05 |
| 2014-12-31 | $4.59M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-15 | $8.40M derived: sum of 2 quarters · filed 2016-03-15 | $12.81M derived: sum of 3 quarters · filed 2016-03-15 | $16.87M 10-K · filed 2016-03-15 |
| 2014-09-30 | $3.81M 10-Q · filed 2015-11-05 | $8.22M derived: sum of 2 quarters · filed 2015-11-05 | $12.28M 10-Q · filed 2015-11-05 | $16.46M derived: sum of 4 quarters · filed 2016-03-15 |
| 2014-06-30 | $4.41M 10-Q · filed 2015-08-05 | $8.48M 10-Q · filed 2015-08-05 | $12.66M derived: sum of 3 quarters · filed 2016-03-15 | $16.40M derived: sum of 4 quarters · filed 2016-03-15 |
| 2014-03-31 | $4.06M 10-Q · filed 2015-05-07 | $8.24M derived: sum of 2 quarters · filed 2016-03-15 | $11.99M derived: sum of 3 quarters · filed 2016-03-15 | $15.14M derived: sum of 4 quarters · filed 2016-03-15 |
| 2013-12-31 | $4.18M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-15 | $7.93M derived: sum of 2 quarters · filed 2016-03-15 | $11.08M derived: sum of 3 quarters · filed 2016-03-15 | $13.50M 10-K · filed 2016-03-15 |
| 2013-09-30 | $3.75M 10-Q · filed 2014-10-31 | $6.90M derived: sum of 2 quarters · filed 2014-10-31 | $9.32M 10-Q · filed 2014-10-31 | $11.57M derived: sum of 4 quarters · filed 2014-10-31 |
| 2013-06-30 | $3.15M 10-Q · filed 2014-08-12 | $5.58M 10-Q · filed 2014-08-12 | $7.82M derived: sum of 3 quarters · filed 2014-08-12 | $9.63M derived: sum of 4 quarters · filed 2014-08-12 |
| 2013-03-31 | $2.43M 10-Q · filed 2014-05-13 | $4.67M derived: sum of 2 quarters · filed 2014-05-13 | $6.48M derived: sum of 3 quarters · filed 2014-05-13 | $8.26M derived: sum of 4 quarters · filed 2014-05-13 |
| 2012-12-31 | $2.25M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-14 | $4.05M derived: sum of 2 quarters · filed 2014-03-14 | $5.84M derived: sum of 3 quarters · filed 2014-03-14 | $8.00M 10-K · filed 2014-03-14 |
| 2012-09-30 | $1.80M 10-Q · filed 2013-11-12 | $3.59M derived: sum of 2 quarters · filed 2013-11-12 | $5.75M 10-Q · filed 2013-11-12 | $9.02M derived: sum of 4 quarters · filed 2013-11-12 |
| 2012-06-30 | $1.79M 10-Q · filed 2013-08-08 | $3.95M 10-Q · filed 2013-08-08 | $7.21M derived: sum of 3 quarters · filed 2013-08-08 | $10.49M derived: sum of 4 quarters · filed 2013-08-08 |
| 2012-03-31 | $2.17M 10-Q · filed 2013-05-14 | $5.43M derived: sum of 2 quarters · filed 2013-05-14 | $8.70M derived: sum of 3 quarters · filed 2013-05-14 | $11.07M derived: sum of 4 quarters · filed 2013-05-14 |
| 2011-12-31 | $3.26M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-12 | $6.53M derived: sum of 2 quarters · filed 2013-03-12 | $8.91M derived: sum of 3 quarters · filed 2013-03-12 | $11.20M 10-K · filed 2013-03-12 |
| 2011-09-30 | $3.27M 10-Q · filed 2012-11-09 | $5.65M derived: sum of 2 quarters · filed 2012-11-09 | $7.94M 10-Q · filed 2012-11-09 | |
| 2011-06-30 | $2.37M 10-Q · filed 2012-07-30 | $4.67M 10-Q · filed 2012-07-30 | ||
| 2011-03-31 | $2.29M 10-Q · filed 2012-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ENDRA Life Sciences Inc. (NDRA) | United States | $0.009B | |
| IRIDEX CORP (IRIX) | United States | $0.011B | |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B |